Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study
(Q28279362)
scientific article
scientific article
Language:
Current Data About
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study